drugset / Trial / NCT00101998

Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

NCT00101998

Phase 2 Completed 233 enrolled Merck & Co., Inc. GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter study to evaluate the effectiveness and safety of multiple dosage regimens of an investigational drug for the treatment of constipation due to prescription pain medication in subjects with cancer pain. The study will require five visits over a five-week period.

Timeline

Start
2003-10-01
Primary completion
2006-05-01
Completion
2006-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Alvimopan Small molecule 0.5 mg Oral
Subject Alvimopan Small molecule 1 mg Oral

Indications